Intrinsiqq
Alvotech logo

Alvotech Financials

ALVO

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$492$586$490$91$83$37
Cost of Revenue$195$236$185$161$64$0
Gross Profit$297$351$304-$69$19$37
Total Operating Expenses$250$273$235$285$365$272
Operating Income$48$78$70-$355-$346-$235
Non-Operating
Net Interest Expense-$143-$137-$154-$133-$77-$113
Income Tax Expense$147$108$14-$99-$38-$48
Net Income
Net Income-$180$28-$232-$552-$514-$102
Per Share Data
Revenue Per Share$1.58$2.10$1.84$0.40$0.42–
EPS (Basic)-$0.58$0.10-$0.87-$2.43-$2.60–
EPS (Diluted)-$0.58$0.10-$0.87-$2.43-$2.60–
Shares Outstanding312.2M279.2M266.5M227.3M197.5M–

Alvotech (ALVO) financials: revenue, profit and margins

Alvotech (ALVO) generated about $492 million in revenue and -$180 million in net income (a -36.5% net margin) over the trailing twelve months, growing at roughly 99.8% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Alvotech's (ALVO) revenue?+

Alvotech generated about $492 million in revenue over the trailing twelve months. Revenue has grown at roughly 99.8% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Alvotech profitable?+

Alvotech reported about -$180 million in net loss over the trailing twelve months, a net margin of roughly -36.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Alvotech's profit margins?+

Alvotech runs a gross margin of about 60.4%, an operating margin of about 9.7%, a net margin of about -36.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Alvotech growing?+

Alvotech's revenue has compounded at roughly 99.8% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ALVO's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Drug Manufacturers - Specialty & Generic · Pick stocks to compare with ALVO

CompareIntrinsic value
OMDA.XOSLOmda A/S
€4.07-0.25%42
BLC.XPARBastide Le Confort Médical
€19.14-0.21%51
GHC.XMILGarofalo Health Care S.p.A.
€5.08+0.00%40
BOI.XPARBoiron SA
€18.85-1.31%41
VETO.XPARVetoquinol SA
€85.70-0.70%63
AYRWFAyr Wellness Inc.
$0.00+0.00%21
VISTN.XOSLVistin Pharma ASA
€1.76+0.57%81
VIMIAN.XSTOVimian Group AB
€3.88+1.57%57

Held by ETFs

ALVO is in 9 US ETFs. The largest of them, with ALVO's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALVO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.